PubMed HealthSearch

PubMed · 3247180

[Fluorometry and uveitis].

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C Hamel, E Bloch-Michel, M Offret, S Chhor, H Offret. [Fluorometry and uveitis].. https://pubmed.ncbi.nlm.nih.gov/3247180/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Effect of morphological abnormalities on blood retinal barrier permeability in diabetic retinopathy.

The morphological base for the impaired function of the blood retinal barrier was studied in 50 eyes of 10 insulin dependent and 21 non-insulin dependent patients with various levels of diabetic retinopathy. The permeability of the blood retinal barrier (PBRB) was determined by vitreous fluorophotometry with correction for autofluorescence, lens transmission and non-protein bound plasma fluorescein concentration. Morphological abnormalities of diabetic retinopathy assessed by fundus photography and fluorescein angiography were individually scored on a decimal scale and related to the PBRB by multiple regression analysis. The PBRB was not correlated to morphological abnormalities of non-proliferative retinopathy [(1) microaneurysms, (2) hard exudates, (3) soft exudates, (4) intraretinal hemorrhages, (5) fluorescein leakage, and (6) capillary closure, p greater than 0.3]. The PBRB was correlated to morphological abnormalities of (pre)proliferative retinopathy [(1) intraretinal microvascular abnormalities (SIRMA) and (2) new vessels (Sneo): PBRB = A+B.SIRMA + C.Sneo with PBRB in nm/sec, A = 1.5 +/- 0.5, B = 0.9 +/- 0.2 and C = 1.7 +/- 0.4, R2 = 0.65, p less than 0.0001]. It can be concluded that the increased blood retinal barrier permeability in diabetic patients is mainly due to (pre)proliferative abnormalities and not to non-proliferative abnormalities.

Blood-Retinal Barrier

[Laser treatment in diabetes-related eye complications].

Argon laser photocoagulation for diabetic retinopathy predominantly involves scatter photocoagulation of either the macula (for diabetic macular edema) or a large portion of the retina (panretinal photocoagulation). In both cases the laser treatment destroys a part of the photoreceptor layer, allowing the diffusion of oxygen and nutrients from the choroid to the inner retina, thus improving the metabolic state of the inner retina. Metabolic imbalance (hypoxia) can be linked with diabetic macular edema through hemodynamic principles according to Starlings law. The connection between the metabolic imbalances and retinal neovascularization is less clear and may involve chemical mitogens, hemodynamic considerations and other unknown factors.

Blood-Retinal Barrier